November is recognized as Lung Cancer Awareness Month all over the world. New and advanced researches continue to work in the arena of lung cancer treatment. The University of Barcelona and Hospital…
Tag: Treatment Options For Lung Cancer
Lung Cancer Awareness Month: Latest Researches in Lung Cancer Treatment
Lung Cancer Awareness Month is observed every year in the month of November. It intends to educate public about signs and symptoms of lung cancer. Creating awareness about this deadly disease is…
New Study Could Help in Personalizing Lung Cancer Treatment
Researchers at the University of Copenhagen have used highly sophisticated molecular analyzes for the purpose of identifying key proteins that signal pathways which lung cancer uses to spread in the body. The…
Researchers Link Genetic Mutations to Improved Outcomes in Lung Cancer Patients
Researchers have presented new findings related to lung cancer at the European Society for Medical Oncology (ESMO) conference in Barcelona, Spain. These new findings by Yale Cancer Center scientists have found that…
E-Sniffer to Predict Best Lung Cancer Treatment
The researchers have developed a novel device to distinguish between those who and will not respond to immunotherapy. They have reported in the Annals of Oncology that eNose was better at identifying…
Considering Unique Cancer Traits for Targeted Therapies
Lung cancer researchers Dr Kate Sutherland and Dr Sarah Best from the Walter and Eliza Hall Institute led the research and it has been published in Nature Communications journal. They have discovered…
Researchers Identify Possible New Lung Cancer Treatment
Lung cancer is the second most common form of lung cancer found in men and women. According to the latest statistics, around 228000 new lung cancer cases and nearly 30% of those…
Pairing Lung and Breast Cancer Drugs More Effective in Killing Cancer Cells
According to the new study, if the drugs used to treat breast and lung cancer are combined, they overcome resistance to treatment. The study is published in the Journal Oncogene and was…